Mon, 27 Jul 2026 · LIVE
Updated Jul 27, 2026 · 20:35
Business India News Updated Jul 27, 2026

Tata Chemicals Posts Rs 17 Crore Net Loss in Q1 Amid Margin Squeeze

Tata Chemicals reported a consolidated net loss of Rs 17 crore for Q1 FY27, compared to a net profit of Rs 252 crore in the same period last year. Revenue grew 14.4% year-on-year to Rs 4,255 crore, driven by higher sales and production volumes. However, EBITDA margin contracted sharply to 13% from 17.5%, as operating performance remained under pressure. The company is transitioning its portfolio towards non-cyclical businesses to build a more resilient growth platform.

Tata Chemicals slips into Rs 17 crore loss in Q1 as margins shrink

Mumbai, July 27

Tata Chemicals Limited on Monday reported a consolidated net loss of Rs 17 crore for the first quarter of FY27, compared with a net profit of Rs 252 crore in the corresponding period last year.

The Tata Group company posted revenue from operations of Rs 4,255 crore for the quarter ended June 30, 2026, marking a 14.4 per cent year-on-year increase from Rs 3,719 crore in the year-ago period, according to its stock exchange filing.

Commenting on the performance, Tata Chemicals Managing Director and Chief Executive Officer R. Mukundan said the company delivered a resilient performance in the June quarter despite a challenging external environment.

"During Q1 FY27, amidst challenging external environment, the company delivered a resilient performance, supported by higher sales and production volumes, strong operating efficiencies and disciplined cost management," Mukundan stated.

"However, exports from USA to Southeast Asia remained under pressure due to persistent unremunerative soda ash pricing," he added.

Despite the double-digit growth in revenue, operating performance remained under pressure.

Earnings before interest, tax, depreciation and amortisation (EBITDA) fell 14.5 per cent to Rs 555 crore from Rs 649 crore a year earlier.

Consequently, the EBITDA margin contracted sharply to 13 per cent from 17.5 per cent in the corresponding quarter of the previous fiscal.

The decline in operating margins weighed on the company's bottom line, pushing Tata Chemicals into a quarterly loss despite higher sales.

The results indicate that cost pressures and an unfavourable operating environment offset the benefits of increased revenue during the reporting period.

Mukundan said the company is transitioning its portfolio towards non-cyclical businesses through focused capital allocation to build a structurally resilient growth platform with more stable earnings.

"Transitioning the portfolio to non-cyclical segments, with focused capital allocation to build a structurally resilient growth platform with stable earnings," he mentioned.

— IANS

Reader Comments

Priya S

This is concerning. Tata is a trusted name in Indian households, and such losses despite higher sales show how external factors like US export pricing hurt us. But Mr. Mukundan seems optimistic about restructuring — let's see if that brings stability.

James A

Interesting case study in global supply chains. Revenue up but profit down — classic margin compression. Tata's move to non-cyclical segments sounds smart, but execution is key. Will be watching their Q2 results closely.

Vikram M

Soda ash pricing is cyclical — this is expected. But Rs 17 crore loss from Rs 252 crore profit last year is a big swing. Tata needs to diversify more into specialty chemicals or agri solutions. Abhi time hai, but management should act fast.

Kavya N

Honestly, I'm not surprised. Global commodity markets are volatile, and India's chemical sector faces stiff competition from China. But I appreciate that Tata is transparent about the challenges. Let's hope the non-cyclical pivot works — for employees and shareholders alike.

Michael C

EBITDA down 14.5% despite revenue growth? That's a red flag for cost management. I'm skeptical about the "resilient performance" claim — resilient would mean protecting margins. But Tata has a long history of bouncing back, so I'll give them the benefit of the doubt.

S We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Reader Voices

Leave a comment

Be kind. Add to the conversation. 0/50
Thank you — your comment has been submitted.
JS blocked